Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin

Despite new and exciting research and renewed optimism about future therapy, current statistics of survival from pancreatic cancer remains dismal. Patients seeking alternative or complementary treatments should be warned to avoid the hype and instead look to real science. A variety of relatively saf...

Descripción completa

Detalles Bibliográficos
Autor principal: Bigelsen, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049054/
https://www.ncbi.nlm.nih.gov/pubmed/30034255
http://dx.doi.org/10.2147/CMAR.S161824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049054/
https://www.ncbi.nlm.nih.gov/pubmed/30034255
http://dx.doi.org/10.2147/CMAR.S161824

Ejemplares similares